About RefleXion
RefleXion is a company based in Hayward (United States) founded in 2009 by Samuel Mazin.. RefleXion has raised $553.91 million across 18 funding rounds from investors including Pfizer, Johnson & Johnson and T. Rowe Price. RefleXion offers products and services including SCINTIX Therapy and RefleXion X1. RefleXion operates in a competitive market with competitors including Alpha Tau Medical, Mevion Medical Systems, ZAP-X, Starget Pharma and Leo Cancer Care, among others.
- Headquarter Hayward, United States
- Founders Samuel Mazin
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Reflexion Medical
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$553.91 M (USD)
in 18 rounds
-
Latest Funding Round
$106.71 M (USD), Series F
Nov 13, 2023
-
Investors
Pfizer
& 20 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RefleXion
RefleXion offers a comprehensive portfolio of products and services, including SCINTIX Therapy and RefleXion X1. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Utilizes cancer emissions for real-time tumor tracking and treatment.
Combines PET imaging with radiotherapy to target moving tumors.
Unlock access to complete
Unlock access to complete
Funding Insights of RefleXion
RefleXion has successfully raised a total of $553.91M across 18 strategic funding rounds. The most recent funding activity was a Series F round of $106.71 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 18
- Last Round Series F — $106.7M
-
First Round
First Round
(01 Jul 2010)
- Investors Count 21
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2023 | Amount | Series F - RefleXion | Valuation | The Rise Fund | |
| Jul, 2022 | Amount | Debt – Conventional - RefleXion | Valuation |
investors |
|
| Mar, 2022 | Amount | Series E - RefleXion | Valuation | Ascension , Catalio Capital Management |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in RefleXion
RefleXion has secured backing from 21 investors, including venture fund and institutional investors. Prominent investors backing the company include Pfizer, Johnson & Johnson and T. Rowe Price. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sector-agnostic VC investment company investing globally
|
Founded Year | Domain | Location | |
|
Private equity and hedge fund investments in healthcare are managed.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on tech sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by RefleXion
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - RefleXion
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Reflexion Comparisons
Competitors of RefleXion
RefleXion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alpha Tau Medical, Mevion Medical Systems, ZAP-X, Starget Pharma and Leo Cancer Care, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Radiotherapy technique for solid tumors is developed using alpha-emitting seeds.
|
|
| domain | founded_year | HQ Location |
Proton therapy systems are supplied for cancer radiation treatment.
|
|
| domain | founded_year | HQ Location |
Developer of gyroscopic radiosurgery platform
|
|
| domain | founded_year | HQ Location |
Targeted radiopharmaceuticals are developed for solid tumor treatment.
|
|
| domain | founded_year | HQ Location |
Advanced radiotherapy devices for cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Reflexion
Frequently Asked Questions about RefleXion
When was RefleXion founded?
RefleXion was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Where is RefleXion located?
RefleXion is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Who is the current CEO of RefleXion?
Todd Powell is the current CEO of RefleXion.
Is RefleXion a funded company?
RefleXion is a funded company, having raised a total of $553.91M across 18 funding rounds to date. The company's 1st funding round was a Series E of $80M, raised on Jul 01, 2010.
What does RefleXion do?
RefleXion was founded in 2009 and is headquartered in Hayward, United States. The company operates in the medical technology sector, focusing on radiotherapy solutions. Its technology integrates Positron Emission Tomography to enable real-time tumor tracking and personalized radiation delivery. Applications target lung, prostate, and breast cancers, supporting precise treatment processes in oncology care.
Who are the top competitors of RefleXion?
RefleXion's top competitors include Alpha Tau Medical, Starget Pharma and ABK Biomedical.
What products or services does RefleXion offer?
RefleXion offers SCINTIX Therapy and RefleXion X1.
Who are RefleXion's investors?
RefleXion has 21 investors. Key investors include Pfizer, Johnson & Johnson, T. Rowe Price, HHS, and Hillenbrand.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.